Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000907:Antibodies, Bacterial / Q000097:blood; D017963:Azithromycin / Q000627:therapeutic use*; D023521:Chlamydophila Infections / Q000150:complications; D016993:Chlamydophila pneumoniae / Q000276:immunology*; D003327:Coronary Disease / Q000382:microbiology* / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D016016:Proportional Hazards Models
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D017963:Azithromycin